Top Downloads

Abiomed Cardiogenic Shock Protocol


Data

New PROTECT III Data Demonstrates Impella® Reduces MACCE Compared to IABP

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


12.05.19
Complete Revascularization Summit: Optimizing Outcomes in Protected PCI | Phoenix 2019
Scottsdale, AZ
12.09.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
01.11.20
Orlando Surgical Skills Workshop
Orlando, FL
Presentations

Jeffrey J. Popma, MD, Presents Data from PROTECT III Study

Watch this breakfast symposium presentation featuring data from the 2-year study of high-risk PCI patients supported with Impella and IABP

Training

Attend The Complete Revascularization Summit

Interventionalist seeking to better understand complex PCI in the modern era

Presentations

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study

A recent study has shown that #Impella use prior to PCI for acute myocardial infarction complicated by #cardiogenicshock has been associated with higher survival among women. You can review the data from the study here: bit.ly/2Kp3Hx7 pic.twitter.com/SD2uCqYWX6

From Protected PCI's Twitter

Employees at Abiomed's Tokyo office recently signed a Japanese version of the "I Am Abiomed Patients First Commitment." The "I Am Abiomed" commitment which defines our culture, mission and values. #PatientsFirst #HeartRecovery pic.twitter.com/sfXL3SPKYx

From Abiomed's Twitter